Galectin Therapeutics Inc.
(NASDAQ : GALT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.46%201.741.2%$403.96m
GILDGilead Sciences, Inc.
-0.52%72.400.9%$392.41m
CELGCelgene Corporation
0.55%87.681.2%$341.00m
BIIBBiogen Inc.
0.16%334.941.2%$274.41m
ILMNIllumina, Inc.
0.34%348.413.5%$253.11m
REGNRegeneron Pharmaceuticals, Inc.
-0.65%383.992.6%$208.88m
EXASExact Sciences Corporation
-1.24%72.4225.3%$196.22m
VRTXVertex Pharmaceuticals Incorporated
0.31%176.341.9%$160.36m
SRPTSarepta Therapeutics, Inc.
-0.49%151.6116.4%$124.26m
AAgilent Technologies, Inc.
-0.09%69.021.5%$121.39m
ALXNAlexion Pharmaceuticals, Inc.
0.54%118.452.0%$108.08m
ALNYAlnylam Pharmaceuticals, Inc
-0.25%93.129.7%$95.58m
NKTRNektar Therapeutics
-1.26%57.585.6%$94.76m
BMRNBioMarin Pharmaceutical Inc.
0.27%98.414.4%$90.92m
INCYIncyte Corporation
0.42%67.302.5%$88.07m

Company Profile

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.